Concepedia

The Introduction of Generic Aromatase Inhibitors and Treatment Adherence Among Medicare D Enrollees

Joan Neuner, Sailaja Kamaraju, John A. Charlson, Erica Wozniak, Elizabeth C. Smith, Alana Biggers, Alicia Smallwood, Purushottam W. Laud, Liliana E. Pezzin

JNCI Journal of the National Cancer Institute · 2015 · 46 citations · 32 references

DOIFull text

Open access

Abstract

The introduction of generic medications attenuated the decline in adherence to AIs over three years of treatment among breast cancer survivors not receiving low-income subsidies for Medicare D coverage.

References

32

Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer

Reiki Nishimura, Tomofumi Osako, Yasuyuki Nishiyama et al. · Oncology · 2013 · 13.2K citations · Full text

Adherence to Medication

Lars Osterberg, Terrence F. Blaschke · New England Journal of Medicine · 2005 · 7.8K citations

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

The Lancet · 2011 · 3K citations · Full text

, , +11

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

Christina Davies, Hongchao Pan, Jon Godwin et al. · The Lancet · 2012 · 2K citations · Full text

, , +7

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer

Dawn L. Hershman, Theresa Shao, Lawrence H. Kushi et al. · Breast Cancer Research and Treatment · 2010 · 868 citations

, , +11